Introduction The coronavirus disease 2019 (COVID-19) pandemic has spread globally.
Therapeutic options including antivirals, anti-inflammatory compounds, and vaccines are still …

Background There is still a lack of consensus on the efficacy of convalescent plasma (CP)
treatment in COVID‐19 patients. We performed a systematic review and meta‐analysis to …

Convalescent plasma is currently being used in the treatment of COVID-19.
Recommendations regarding use convalescent plasma in COVID-19 requires systematic …

In the absence of definitive therapy for coronavirus disease (COVID‐19), convalescent
plasma therapy (CPT) may be a critical therapeutic option. This review was conducted to …

The collection and clinical use of COVID-19 convalescent plasma (CCP) as a therapy for
COVID-19 infection is under development and early use in many centers worldwide. We …

Insight into the clinical potential of convalescent plasma in patients with coronavirus disease
(COVID-19) is important given the severe clinical courses in unvaccinated and seronegative …

Convalescent plasma is a suggested treatment for Coronavirus disease 2019 (Covid-19),
but its efficacy is uncertain. We aimed to evaluate whether the use of convalescent plasma is …

Convalescent plasma (CP) transfusion has been indicated as a promising therapy in the
treatment for other emerging viral infections. However, the quality control of CP and …

Importance/Background: With a scarcity of high-grade evidence for COVID-19 treatment,
researchers and health care providers across the world have resorted to classical and …

The recent emergence of coronavirus disease 2019 (COVID‐19) pandemic has reassessed
the usefulness of historic convalescent plasma transfusion (CPT). This review was …